Clinical Trial Update: Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a personalized neo-antigen vaccine (NeoPepVac) in advanced solid tumors across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma Metastatic
• Malignant Melanoma Metastatic
• Non-small Cell Lung Cancer Metastatic

Drugs mentioned

• NeoPepVac (neoantigen vaccine)

Snippet

Sponsor: Herlev Hospital | Conditions: Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic | Phase 1, Phase 2 | Status: UNKNOWN